Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.40 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.38 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.37 |
| ▸ | STS | P08842 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16680564 | 0.88 | HSD17B10 (0.53) | HSD17B10HPGDRECQLCHRM2CHRM1 | |
| SCHEMBL31069004 | 0.88 | HSD17B10 (0.53) | HSD17B10HPGDRECQLCHRM2CHRM1 | |
| SCHEMBL31068869 | 0.88 | HSD17B10 (0.44) | HSD17B10HPGDRECQLCHRM2CHRM1 | |
| SCHEMBL23694162 | 0.88 | HSD17B10 (0.44) | HSD17B10HPGDRECQLCHRM2CHRM1 | |
| SCHEMBL16680566 | 0.88 | HSD17B10 (0.53) | HSD17B10HPGDRECQLCHRM2CHRM1 | |
| SCHEMBL23694159 | 0.88 | HSD17B10 (0.44) | HSD17B10HPGDRECQLCHRM2CHRM1 | |
| SCHEMBL15491795 | 0.88 | HSD17B10 (0.44) | HSD17B10HPGDRECQLCHRM2CHRM1 | |
| SCHEMBL24927723 | 0.88 | HSD17B10 (0.53) | HSD17B10HPGDRECQLCHRM2CHRM1 | |
| SCHEMBL31001881 | 0.88 | HSD17B10 (0.53) | HSD17B10HPGDRECQLCHRM2CHRM1 | |
| SCHEMBL2072006 | 0.88 | HSD17B10 (0.53) | HSD17B10HPGDRECQLCHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4688741-A1 | COMPOUNDS FOR TREATING FIBROTIC DISEASES | Meta-Immune, Inc. (KR) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024249867-A1 | COMPOUNDS FOR TREATING FIBROTIC DISEASES | AM SCIENCES (KR) | 2024-12-05 | — | — | WO | disclosed |
| US-6689780-B1 | PYRIDINE DERIVATIVES | ELI LILLY AND COMPANY | 2004-02-10 | — | — | US | disclosed |
| EP-1140905-B1 | HETEROAROMATIC AMIDES AS INHIBITOR OF FACTOR XA | LILLY CO ELI (US) | 2003-05-14 | — | — | EP | disclosed |
| EP-1140905-A1 | HETEROAROMATIC AMIDES AS INHIBITOR OF FACTOR XA | ELI LILLY AND COMPANY (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000039117-A1 | HETEROROAROMATIC AMIDES AS INHIBITOR OF FACTOR Xa | ELI LILLY AND COMPANY (US) | 2000-07-06 | — | — | WO | disclosed |